Cronos Group Inc
TSX:CRON

Watchlist Manager
Cronos Group Inc Logo
Cronos Group Inc
TSX:CRON
Watchlist
Price: 4.49 CAD 14.83% Market Closed
Market Cap: 1.7B CAD

Net Margin
Cronos Group Inc

27.3%
Current
-80%
Average
4.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
27.3%
=
Net Income
36.1m
/
Revenue
132.4m

Net Margin Across Competitors

Country Company Market Cap Net
Margin
CA
Cronos Group Inc
TSX:CRON
1.7B CAD
27%
US
Eli Lilly and Co
NYSE:LLY
971.9B USD
31%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
US
Johnson & Johnson
NYSE:JNJ
509.1B USD
27%
CH
Roche Holding AG
SIX:ROG
252.3B CHF
15%
UK
AstraZeneca PLC
LSE:AZN
208.5B GBP
16%
CH
Novartis AG
SIX:NOVN
202.4B CHF
26%
US
Merck & Co Inc
NYSE:MRK
249.5B USD
30%
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
33%
IE
Endo International PLC
LSE:0Y5F
209B USD
-126%
US
Pfizer Inc
NYSE:PFE
147B USD
16%
No Stocks Found

Cronos Group Inc
Glance View

Market Cap
1.7B CAD
Industry
Pharmaceuticals

Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The firm is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones, Happy Dance and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones, Happy Dance and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s subsidiaries include Cronos Israel G.S. Cultivation Ltd, Cronos Israel G.S. Manufacturing Ltd., Cronos Israel G.S. Store Ltd. and Cronos Israel G.S. Pharmacy Ltd.

CRON Intrinsic Value
1.98 CAD
Overvaluation 56%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
27.3%
=
Net Income
36.1m
/
Revenue
132.4m
What is the Net Margin of Cronos Group Inc?

Based on Cronos Group Inc's most recent financial statements, the company has Net Margin of 27.3%.

Back to Top